BAYER A.G. (BAYZF)
Clinical trial NCT07446010 updates: 1. start date: 2026-05-29 → 2026-09-01 2. completion date: 2026-12-31 → 2027-09-30 3. primary completion date: 2026-12-31 → 2027-09-30 4. enrollment: not set → 33 participants
Clinical trial NCT07446010 updates: 1. start date: 2026-05-29 → 2026-09-01 2. completion date: 2026-12-31 → 2027-09-30 3. primary completion date: 2026-12-31 → 2027-09-30 4. enrollment: not set → 33 participants
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical